The Impact of Motivational Interviewing and MOTIVE Tool Use by Pharmacists on Vaccine Acceptance

Vaccines have played a significant role in reducing infectious disease burden. However, vaccine hesitancy remains a persistent challenge in public health, including for pharmacists who often interact with patients regarding vaccines. Thus, this study assesses the impact of motivational interviewing...

Full description

Saved in:
Bibliographic Details
Main Authors: Aleda M. H. Chen (Author), Alea Anthony (Author), Adeola Balogun (Author), Ruth Pereira (Author), Justin W. Cole (Author)
Format: Book
Published: MDPI AG, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_9d7cf07929c54e0396fa8c4b51b892c5
042 |a dc 
100 1 0 |a Aleda M. H. Chen  |e author 
700 1 0 |a Alea Anthony  |e author 
700 1 0 |a Adeola Balogun  |e author 
700 1 0 |a Ruth Pereira  |e author 
700 1 0 |a Justin W. Cole  |e author 
245 0 0 |a The Impact of Motivational Interviewing and MOTIVE Tool Use by Pharmacists on Vaccine Acceptance 
260 |b MDPI AG,   |c 2024-07-01T00:00:00Z. 
500 |a 10.3390/pharmacy12040114 
500 |a 2226-4787 
520 |a Vaccines have played a significant role in reducing infectious disease burden. However, vaccine hesitancy remains a persistent challenge in public health, including for pharmacists who often interact with patients regarding vaccines. Thus, this study assesses the impact of motivational interviewing (MI) training and the MI-based vaccine hesitancy discussion tools (MOTIVE) on pharmacists' management of vaccine hesitancy. Pharmacists in eight Midwestern pharmacy practices who completed MI and MOTIVE training and engaged with vaccine-hesitant patients participated in this study. The pharmacist participants completed post-encounter surveys identifying the vaccine discussed, the tool utilized, and the outcome of the conversation. Descriptive results from 362 encounters indicated that the primary reasons for hesitancy were safety (39%), care coordination (31.5%), and efficacy (30.4%). Post encounter, 35.4% of patients received vaccines, 26% planned to, 25.1% considered it, and 13.5% were uninterested. The findings highlight the importance of patient-centered communication, such as MI, between patients and pharmacists to identify and address reasons for vaccine hesitancy. Pharmacists, equipped with conversation tools such as the MOTIVE tools, may effectively influence vaccine acceptance. Future research should evaluate the utility of MI and the MOTIVE tools in other settings and regions. 
546 |a EN 
690 |a vaccine acceptance 
690 |a vaccine hesitancy 
690 |a patient-centered communication 
690 |a motivational interviewing 
690 |a community pharmacy 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmacy, Vol 12, Iss 4, p 114 (2024) 
787 0 |n https://www.mdpi.com/2226-4787/12/4/114 
787 0 |n https://doaj.org/toc/2226-4787 
856 4 1 |u https://doaj.org/article/9d7cf07929c54e0396fa8c4b51b892c5  |z Connect to this object online.